1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Insulin Pens Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Insulin Pens Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Prevalence of Diabetes
5.2 Market Opportunities
- 5.2.1 Technological advancement
5.4 Impact of Drivers and Restraints
6. North America Insulin Pens Market Regional Analysis
6.1 North America Insulin Pens Market Overview
6.2 North America Insulin Pens Market Revenue 2016-2027 (US$ Million)
6.3 North America Insulin Pens Market Forecast Analysis
7. North America Insulin Pens Market Analysis – by Product Type
7.1 Disposable
- 7.1.1 Overview
- 7.1.2 Disposable: North America Insulin Pens Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reusable
- 7.2.1 Overview
- 7.2.2 Reusable: North America Insulin Pens Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Insulin Pens Market Analysis – by Application
8.1 Diabetes Type-1
- 8.1.1 Overview
- 8.1.2 Diabetes Type-1: North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Diabetes Type-2
- 8.2.1 Overview
- 8.2.2 Diabetes Type-2: North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Insulin Pens Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Diabetes Type-2: North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Retail Pharmacies and e-Commerce
- 9.2.1 Overview
- 9.2.2 Diabetes Type-2: North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Insulin Pens Market – North America Analysis
10.1 North America
- 10.1.1 North America Insulin Pens Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 North America Insulin Pens Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Insulin Pens Market Breakdown, by Product Type
- 10.1.1.1.2 US: North America Insulin Pens Market Breakdown, by Application
- 10.1.1.1.3 US: North America Insulin Pens Market Breakdown, by Distribution Channel
- 10.1.1.2 Canada:
North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Insulin Pens Market Breakdown, by Product Type
- 10.1.1.2.2 Canada: North America Insulin Pens Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Insulin Pens Market Breakdown, by Distribution Channel
- 10.1.1.3 Mexico :
North America Insulin Pens Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Insulin Pens Market Breakdown, by Product Type
- 10.1.1.3.2 Mexico : North America Insulin Pens Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Insulin Pens Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Insulin Pens Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Owen Mumford, LTD.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Novo Nordisk a/s
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Companion Medical
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Berlin-Chemie AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pendiq GmbH
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Emperra GmbH E-Health Technologies
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Eli lilly and company
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Ypsomed Ag
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 SANOFI
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Biocon
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Insulin Pens Market
